Loading resource…

Prateek C. Gandiga, Daniela Ghetie, Elizabeth Anderson, Rohit Aggrawal
Idiopathic inflammatory myopathies (IIM) are a complex family of autoimmune systemic disorders that significantly impact muscle and skin. The optimal treatment for IIM remains uncertain, which is why this guide focuses on the use of IVIG and SCIG based on recent literature and clinical experience. It discusses the safety, formulations, and costs associated with IVIG, along with its effectiveness in treating muscular and extra-muscular manifestations of IIM. The guide also addresses special circumstances such as myositis-related dysphagia and interstitial lung disease.
No account needed